Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000287157

Medchemexpress LLC My-875 | 2974348-62-2 | MFCD34676541 | 99.6% | 387.43 | C21H25NO6 | 10 MG
SDP

Supplier:  Medchemexpress LLC HY15076110MG

Encompass_Preferred

MY-875 is a competitive microtubulin polymerization inhibitor that targets the colchicine binding site and activates the Hippo signaling pathway. It induces apoptosis, causes G2/M cell-cycle arrest, and exhibits dose-dependent antiproliferative activity in multiple cancer cell lines; reported tubulin polymerization IC50 is 0.92 μM. The compound is supplied as a high-purity solid with high solubility in DMSO and recommended storage to preserve stability.

  • Competitive microtubulin polymerization inhibitor targeting colchicine binding sites.
  • Activates Hippo pathway leading to YAP degradation.
  • Induces apoptosis and G2/M cell-cycle arrest in cancer cells.
  • Demonstrates potent antiproliferative activity (tubulin polymerization IC50 ~0.92 μM).
  • High purity solid with high DMSO solubility for assay preparation.
  • Stable under recommended storage conditions for experimental reproducibility.

Catalog No. 50-002-87157


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.